A prospective clinical trial exploring the correlation between early ctDNA dynamics and various FDG PET/CT parameters in ICI-treated patients with advanced melanoma
Latest Information Update: 19 Jun 2025
At a glance
- Drugs Ipilimumab/nivolumab (Primary) ; Nivolumab/relatlimab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
Most Recent Events
- 19 Jun 2025 New trial record
- 30 Apr 2025 Results presented at the 116th Annual Meeting of the American Association for Cancer Research